Back to Glossary
Administration Definition

Area Under the Curve

Also known as: AUC, Area under the concentration-time curve, Total drug exposure, AUC0-inf, AUC0-t

Area Under the Curve is a pharmacokinetic measure representing total drug exposure over time, calculated as the integral of the plasma concentration-time curve. AUC reflects the overall amount of drug reaching systemic circulation and is used to assess bioavailability, compare formulations, and determine total drug exposure in therapeutic monitoring.

Last updated: February 1, 2026

Understanding Area Under the Curve

Area Under the Curve (AUC) captures total systemic drug exposure by measuring the entire concentration-time profile. Unlike peak or trough levels that capture single moments, AUC integrates all drug exposure from administration through elimination.

Concentration
     ^
     |     Peak
     |      /\
     |     /  \
     |    /    \
     |   / AUC  \
     |  /________\____
     |        Time →

The shaded area between the curve and the time axis represents the AUC.

Types of AUC Measurements

ParameterDescriptionUse
AUC0-tArea from time 0 to last measurable time pointPractical measurement limit
AUC0-infArea extrapolated to infinityComplete drug exposure
AUC0-tauArea over one dosing interval at steady-stateRepeated dosing exposure

Why AUC Matters

Bioavailability Determination

AUC is the gold standard for assessing how much drug reaches circulation:

Absolute bioavailability:

F = AUC (test route) / AUC (IV) x 100%

Relative bioavailability:

F = AUC (test formulation) / AUC (reference formulation) x 100%

Bioequivalence Testing

Generic drug approval requires demonstrating similar AUC to the reference product:

ParameterBioequivalence Criteria
AUC ratio80-125% of reference
Cmax ratio80-125% of reference
Confidence interval90% CI must fall within bounds

AUC in Peptide Pharmacology

Comparing Administration Routes

AUC reveals dramatic differences in peptide delivery:

Route (for typical peptide)Relative AUC
Intravenous100% (reference)
Subcutaneous70-100%
Intramuscular75-100%
OralTypically less than 1%

Oral Semaglutide Example

The oral formulation (Rybelsus) achieves only ~1% bioavailability:

  • AUC is dramatically lower than subcutaneous
  • Higher oral doses compensate for low bioavailability
  • 14mg oral approximates 0.5mg subcutaneous exposure

Clinical Applications of AUC

Drug Development

AUC guides multiple development decisions:

ApplicationHow AUC Is Used
Dose selectionCorrelate AUC with efficacy/safety
Formulation comparisonEnsure equivalent exposure
Drug interactionsAssess changes in exposure
Special populationsEvaluate impact of renal/hepatic impairment

Therapeutic Monitoring

For some drugs, AUC-based monitoring guides dosing:

  • Certain chemotherapy agents
  • Immunosuppressants
  • Antiretrovirals

Calculating and Interpreting AUC

Calculation Methods

Trapezoidal rule (most common):

  • Divides curve into trapezoids between sampling times
  • Sums trapezoid areas
  • Practical with limited sampling points

Compartmental modeling:

  • Fits data to pharmacokinetic model
  • Calculates AUC from model parameters
  • Allows extrapolation and prediction

Relationships to Other Parameters

RelationshipFormulaMeaning
AUC and ClearanceAUC = Dose / CLHigher clearance = lower AUC
AUC and Half-lifeProportionalLonger half-life = higher AUC
AUC and FAUC = (F x Dose) / CLBioavailability directly affects AUC

Factors Affecting AUC

Drug Factors

  • Dose - Higher dose = proportionally higher AUC (for linear kinetics)
  • Formulation - Affects absorption extent
  • Route - Determines bioavailability

Patient Factors

  • Clearance - Reduced clearance increases AUC
  • Hepatic function - Impairment may increase AUC
  • Renal function - Affects AUC for renally cleared drugs
  • Drug interactions - May alter metabolism and clearance

AUC-Based Dosing Adjustments

For drugs where total exposure drives efficacy or toxicity:

AUC FindingInterpretationPossible Action
Lower than targetInsufficient exposureIncrease dose
Within target rangeAppropriate exposureContinue dosing
Higher than targetExcessive exposureReduce dose

Frequently Asked Questions

How is AUC different from measuring a single blood level?

A single blood level only captures one moment in time. AUC integrates the entire concentration-time profile, accounting for both how high levels go and how long they remain elevated. It provides a complete picture of total drug exposure.

Why is AUC important for comparing drug formulations?

Different formulations may have different absorption rates, leading to different peaks, but the same total amount may ultimately reach circulation. AUC reveals whether total exposure is equivalent, which is essential for therapeutic interchangeability.

Does higher AUC always mean better drug effect?

Not necessarily. Higher AUC means more total exposure, but optimal therapeutic effect depends on achieving concentrations within the therapeutic range. Excessive AUC may increase toxicity without improving efficacy.

Related Peptides

Related Terms

Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.